This session focuses on the genetic underpinnings of neurodevelopmental disorders such as autism spectrum disorders, epilepsy, and intellectual disabilities. Discussions will cover recent discoveries in neurogenetics, including the identification of genetic risk factors, gene-environment interactions, and epigenetic mechanisms influencing brain development and function. Topics will also explore advances in genomic technologies, including next-generation sequencing and genome-wide association studies (GWAS), and their implications for diagnosis, prognostication, and personalized therapies in neurology. The session aims to foster collaboration between geneticists, neuroscientists, and clinicians to accelerate the translation of genetic research findings into clinical practice, ultimately improving outcomes for individuals affected by neurodevelopmental disorders.